The State immunoprophylaxis committee recommends booster doses for 12-17 year olds based on their health. If their state of health makes it essential, boosters can be done with Pfizer/BioNTech vaccine.
“Based on the Estonian data, this age group rarely needs hospitalization. Therefore, for 12-17 year olds need a booster dose only if they have an underlying health condition or a disease that put's them into a risk of falling severely ill,” said the member of the committee, dr Marje Oona.
The assessment if the booster dose is needed is done by a doctor. Boosters might be considered before travelling to the country where there's a high risk of falling ill with a coronavirus.
By the assessment (24.02.2022) of the European Medical Agency's (EMA) committee of human medicines, Pfizer/BioNTech vaccine Comirnaty can be used as a booster dose for children aged 12 and above. The objective of a booster dose is to restore the protectiveness of the vaccine, after it has dropped in time after the first vaccination course. By the current data, the efficacy of the booster doses for youth is similar to the adults. No new safety risks were discovered.
The Estonian Immunoprophylaxis Expert Committee advises the Ministry of Social Affairs about the state immunization and other vaccination-related topics. It includes representatives of allergist-immunologists, family physicians, paediatrics, infectionists, nurses, National Health Board, the Agency of Medicines, Estonian Health Insurance Fund, and the Ministry of Social Affairs.
Time-slots for booster doses for 12-17-year-olds will be available via Digital Registry from the 24th of March.
Source: Ministry of Social Affairs